PDS Biotechnology Corp Oncology R&D Day Transcript
Hello, and welcome to the PDS Biotechnology R&D Day. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Deanne Randolph, Vice President, Commercial Development. Please go ahead.
Good morning, and welcome to PDS Biotechnology's Oncology R&D Day Teleconference and Webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Dr. Jeffrey Schlom; Dr. Caroline Jochems; and Dr. Julius Strauss from the National Cancer Institute. I will provide formal introductions in a moment.
But before we begin, I would like to caution listeners that comments made by management during the conference call will include forward-looking statements within the meaning of Federal Securities laws, including the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve material risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |